Notes on Autonomic and Somatic Nervous Systems

Autonomic and Somatic Nervous Systems

Autonomic Nervous System (ANS)

  • Functions: Regulates activity in smooth muscle, cardiac muscle, and glands (visceral organs).
  • Roles: Increases (Excitation) or decreases (Inhibition) ongoing activities.
  • Branches:
    • Sympathetic: Prepares body for emergencies (Fight or Flight).
    • Parasympathetic: Conserves and restores energy (Rest and Digest).
    • Enteric: Discussed in digestive system (Chapter 21).
  • Dual Innervation: Most organs receive input from both sympathetic and parasympathetic systems.
  • Pathway Composition: Comprised of two neurons - preganglionic and postganglionic.

Parasympathetic Division

  • Craniosacral Division: Preganglionic neurons exit the CNS from the brain stem and sacral spinal cord.
  • Terminal Ganglia: Preganglionic fibers synapse close to or at the target organs.
  • Key Nerves:
    • Oculomotor (III): Influences ciliary muscle for eye accommodation.
    • Facial (VII): Innervates glands (tear, saliva).
    • Glossopharyngeal (IX): Innervates salivary glands through otic ganglion.
    • Vagus (X): Major nerve that innervates the thoracic and abdominal organs.
  • Sacral Nerves: Innervate lower parts of large intestine, rectum, urinary, and reproductive organs.

Sympathetic Division

  • Thoracolumbar Division: Preganglionic neurons located in the thoracic and lumbar regions (T1-L2).
  • Ganglia: Includes paravertebral (sympathetic chain) and collateral (prevertebral) ganglia.
    • Paravertebral Ganglia: Interconnected ganglia alongside the spinal cord.
    • Collateral Ganglia: Splanchnic nerves synapse here impacting digestive, urinary, reproductive organs.
  • Adrenal Medulla: Releases epinephrine and norepinephrine, extending the sympathetic response duration.

Neuroeffector Junction

  • Definition: Synapse between autonomic postganglionic neurons and visceral effectors.
  • Mechanism: Uses varicosities; neurotransmitters diffuse across the synapse to bind with receptors.
  • Signal Transmission Process:
    1. Action potentials trigger Ca²⁺ influx at varicosities.
    2. Ca²⁺ stimulates neurotransmitter release.
    3. Neurotransmitter binding activates G proteins leading to excitation or inhibition.

Types of Neurotransmitters and Receptors

Cholinergic

  • Neurotransmitter: Acetylcholine (ACh) used by all preganglionic neurons, most parasympathetic postganglionic, and some sympathetic postganglionic (e.g., sweat glands).
  • Receptors:
    • Nicotinic: Located at neuromuscular junctions and dendrites of autonomic neurons.
    • Muscarinic: Found in smooth muscle and glands.

Adrenergic

  • Neurotransmitters: Norepinephrine and Epinephrine, primarily released by the sympathetic system.
  • Receptor Types:
    • Alpha (α): Found in most sympathetic target tissues; promotes excitatory effects.
    • Beta (β): Has multiple subtypes affecting various tissues with excitatory or inhibitory outcomes.

Autonomic Effects

  • Sympathetic Stimuli: Increases heart rate, vasoconstriction, inhibits digestive functions, promotes glucose release, and prepares the body for emergencies.
  • Parasympathetic Stimuli: Decreases heart rate, promotes digestion (SLUDD - Salivation, Lacrimation, Urination, Digestion, Defecation), and conserves energy.
  • Balancing Activity: Homeostasis maintained by autonomic tone, dependent on hypothalamic regulation.

Somatic Nervous System (SNS)

  • Regulation: Governs voluntary control of skeletal muscle.
  • Structure: Composed of a single somatic motor neuron connecting directly with skeletal muscle fibers.

Neuromuscular Junction (NMJ)

  • Components: Synaptic end bulb releases ACh; the motor end plate has receptors that cause excitatory effects.

Signal Transduction at NMJ

  • Process:
    1. Action potential arrives, opening voltage-gated Ca²⁺ channels.
    2. Release of ACh triggering muscle action potential through Na⁺ influx.

Disturbances in NMJ Function

  • Botulinum toxin: Blocks ACh release, can cause paralysis.
  • α-latrotoxin: Leads to excessive ACh release, potentially causing respiratory failure.
  • Curare: Blocks ACh receptors, used during surgery.
  • Organophosphates: Inhibit acetylcholinesterase, prolonging ACh effects.